Hamid Tavakkoli

Hamid Tavakkoli

Auto-generated profile, based on publicly available information

Hamid Tavakkoli

Department of Gastroenterology, Isfahan University of Medical Sciences, Isfahan, Iran

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Complementary Therapies in Clinical Practice
Verified
Journal Article
Closed access
MKMohammadali Kamali
Mohammadali Kamali
HTHamid Tavakoli
Hamid Tavakoli
MKMahmood Khodadoost
Mahmood Khodadoost
HDHamed Daghaghzadeh
Hamed Daghaghzadeh
MKMohammad Kamalinejad
Mohammad Kamalinejad
PAPayman Adibi
Payman Adibi

1 January 2016
Verified
Journal Article
Closed access
MMMasoud M Malekzadeh
Masoud M Malekzadeh
HVHomayoon Vahedi
Homayoon Vahedi
KGKimiya Gohari
Kimiya Gohari
PMParinaz Mehdipour
Parinaz Mehdipour
SSSadaf G. Sepanlou
Sadaf G. Sepanlou
RMReza Malekzadeh
Reza Malekzadeh

1 January 2015 in Journal of Research in Medical Sciences
Verified
Journal Article
Open access
PDF file
MSMohammad Reza Sharbafchi
Mohammad Reza Sharbafchi
HDHamed Daghaghzadeh
Hamed Daghaghzadeh
FNFateme Naji
Fateme Naji
HAHamid Afshar
Hamid Afshar
AFAwat Feizi
Awat Feizi
HTHamid Tavakoli
Hamid Tavakoli
Background: Treating inflammatory bowel disease (IBD) with antidepressants might be of utility to improve patient's condition. The aim of this study was to assess the efficacy of Duloxetine on depression, anxiety, severity of symptoms, and quality of life (QOL) in IBD patients. Materials and Methods: In a randomized, double-blind, controlled clinical trial on 2013-2014, in Alzahra Hospital (Isfahan, Iran), 44 IBD patients were chosen to receive either duloxetine (60 mg/day) or placebo. They were treated in a 12 weeks program, and all of the participants also received mesalazine, 2-4 g daily. We assessed anxiety and depression with Hospital Anxiety and Depression Scale, the severity of symptoms with Lichtiger Colitis Activity Index and QOL with World Health Organization Quality of Life Instruments, before and just after the treatment. The data were analyzed using Paired sample t-test and ANCOVA. Results: In 35 subjects who completed the study, the mean (standard error [SE]) scores of depression and anxiety were reduced in duloxetine more than placebo group, significantly (P = 0.041 and P = 0.049, respectively). The mean (SE) scores of severity of symptom were also reduced in duloxetine more than the placebo group, significantly (P = 0.02). The mean (SE) scores of physical, psychological, and social dimensions of QOL were increased after treatment with duloxetine more than placebo group, significantly (P = 0.001, P = 0.038, and P = 0.015, respectively). The environmental QOL was not increased significantly (P = 0.260). Conclusion: Duloxetine is probably effective and safe for reducing depression, anxiety and severity of physical symptoms. It also could increase physical, psychological, and social QOL in patients.

1 January 2011
Verified
Journal Article
Open access
MMMohammad Mehdi Mir-Nasseri
Mohammad Mehdi Mir-Nasseri
AMAshraf MohammadKhani
Ashraf MohammadKhani
HTHamid Tavakkoli
Hamid Tavakkoli
EAEsmaeil Ansari
Esmaeil Ansari
HPHossein Poustchi
Hossein Poustchi
There is a strong association between hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infection which are mainly transmitted by contamination with blood via intravenous drug abuse (IVDU) or sexual contact. To determine the prevalence of these infections and the risk factors associated with them among prisoner and non-prisoner IVDUs in Tehran, Iran. This cross-sectional study was performed in two jails and three drug rehabilitation centers between 2001 and 2002 in Tehran. HBsAg and HBcAb were checked using highly specific third generation enzyme immunoassays (DIA.PRO, Italy, specificity >99%, and Radim, Italy, specificity 99.7%, respectively). HCVAb was detected using ELISA (DIA.PRO, Italy) with both sensitivity and specificity >98%. HIVAb test (DRG Diagnostics kit, Germany) was performed for 459 of the 468 IDU subjects. 392 prisoners and 135 individual attending drug rehabilitation centers were approached. Of the 518 subjects studied, 464 (89.5%) were male, 386 (74.5%) were prisoners and 132 (25.5%) were non-prisoners. In this study, HBsAg, HCVAb and HIVAb were positive in 19 (3.7%), 359 (69.5%) and 70 (15.5%) of subjects, respectively. These tests were positive in 17 (4.5%), 311 (80.5%) and 63 (17%) among prisoners and 2 (1.5%), 48 (36.5%) and 7 (7.8%) in non-prisoners, respectively. Multiple logistic regression analysis revealed that independent factors related to co-infection of HCV and HIV infection were imprisonment (p<0.001. OR: 7.5) and using common syringe (p=0.03, OR: 4.5). Our findings strongly suggest that drug injection inside prison carries is a risk for HIV infection and that HIV infection among IDUs is likely to be bridged to the broader population through sexual contact without using effective prevention programs.

27 December 2006 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
HTHamid Tavakkoli
Hamid Tavakkoli
MAMehrnaz Asadi
Mehrnaz Asadi
MHMahshid Haghighi
Mahshid Haghighi
AEAbbas Esmaeili
Abbas Esmaeili
One of the rare presentations of superior vena cava syndrome is bleeding of "downhill" esophageal varices (DEV) and different approaches have been used to control it. This is a case report whose DEV was eradicated by band ligation for the first time. We report a 42-year-old man who is a known case of Behcet's disease. The patient's first presentation was superior vena cava syndrome due to thrombosis followed by bipolar ulcers and arthralgia. He received warfarin, prednisolone and azathioprine. The clinical course of the patient was complicated by one episode of hematemesis without abdominal pain when the patient's PT was in therapeutic range. After resuscitation and correction of PT with fresh frozen plasma transfusion, upper gastrointestinal endoscopy was done. Prominent varices were seen in the upper third of the esophagus, tapering to the middle part without acute bleeding. Stomach and duodenum were normal. Color ultrasonography evaluation of the portal, hepatic and splenic veins was negative for thrombosis. Band ligation was done and the patient's bleeding did not recur. Band ligation is a safe and effective method for controlling DEV bleeding in patients with uncorrectable underlying disorders.

6 February 2008 in Dysphagia
Verified
Journal Article
Closed access
PDF file
MEMohammad Hassan Emami
Mohammad Hassan Emami
MRMostafa Raisi
Mostafa Raisi
JAJaleh Amini
Jaleh Amini
ATAbbas Tabatabai
Abbas Tabatabai
MHMehran Haghighi
Mehran Haghighi
VGVahid Goharian
Vahid Goharian